Melissa Hollo: How HerCare Utilizes Hierarchical Algorithm of Severe Maternal Morbidity
Melissa Hollo, Director of Project Management at hc1 and Licensed Independent Clinical Social Worker, shared a post on LinkedIn:
A recent study titled ‘Hierarchical algorithm identifies methods of severe maternal morbidity’ by Joshua Fitch, Senior Editor, published in Obstetrics and Gynecology, highlights a significant advancement in our understanding of severe maternal morbidity.
The study emphasizes the need for earlier and more precise identification of risks.
The research introduces a hierarchical algorithm that achieves a 94.5% concordance with manual chart reviews in identifying the primary drivers of maternal morbidity.
Key findings indicate that hemorrhage, hypertension, and infection are major contributors to maternal complications, with hypertension and infection alone responsible for nearly 45% of non-transfusion related cases.
While this study provides clarity on the factors driving maternal morbidity, it also highlights a critical gap in care: risks are often identified only after they have escalated.
At hc1, we are addressing this issue through HerCare.
HerCare utilizes a hierarchical, data-driven approach to identify maternal risk earlier in the care journey, before complications become severe.
By integrating clinical, lab, and longitudinal patient data, we empower providers to proactively detect risks such as iron deficiency, hypertensive disorders, and infections – conditions that significantly contribute to morbidity.
The opportunity lies not just in better classification, but in intervention.
By identifying these risks sooner, we can:
- Improve maternal outcomes and reduce preventable complications
- Decrease costly acute interventions and hospital utilization
- Close the gap between morbidity and mortality drivers through earlier care pathways
We can begin to shift the curve on maternal health by combining clinical insight with actionable intelligence at the point of care.
Learn how we’re supporting earlier maternal risk detection.”
More posts featuring Melissa Hollo on Hemostasis Today.
-
Apr 25, 2026, 10:05Lutz Knabe: One Child’s Journey from Pain to Hope Beyond Severe Bleeding Disorder
-
Apr 25, 2026, 09:58Ulrike Meyer-Lindemann: Can Physical Activity Protect against Stress-Induced Vascular Inflammation
-
Apr 25, 2026, 09:45What If the Diagnosis Isn’t the Full Picture? – TFC
-
Apr 25, 2026, 09:27Syed Ibrahim Bukhari: Sharing a Publication on LBMFS in LMICs
-
Apr 25, 2026, 09:24Rebecca Soskin Hicks: Launching ChatGPT for Clinicians from OpenAl
-
Apr 25, 2026, 09:18Mavis Agnes Kisakye: Uganda Delegation Returns Empowered from WFH 2026
-
Apr 25, 2026, 04:44Tareq Abadl: Not Every Rh-Positive or Rh-Negative Result is That Simple
-
Apr 25, 2026, 04:44Michael Makris: Data Security and Research Integrity in Population Biobanks
-
Apr 25, 2026, 04:43Muriel De Vos: Real-World Outcomes in Haemophilia A Without Inhibitors in the United States